Literature DB >> 17786850

Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.

Katalin Karikó1, Drew Weissman.   

Abstract

DNA and RNA stimulate the mammalian innate immune system by triggering a variety of sensors, including Toll-like receptors (TLRs). TLR9 signals upon exposure to DNA, while TLR3, TLR7 and TLR8 respond to RNA. Most DNA and RNA from natural sources contain modified nucleosides. Methylation of CpG motifs in DNA blocks TLR9 signaling. The question of whether an analogous effect can be attributed to nucleoside modifications in RNA has only recently been addressed. This review characterizes a few naturally occurring nucleoside modifications of RNA and their influence on the capacity of RNA to activate immune cells and TLRs. RNAs containing modified nucleosides, and thus lacking immune-activating properties, have potential importance in clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786850

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  45 in total

1.  Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.

Authors:  Subba Rao Nallagatla; Philip C Bevilacqua
Journal:  RNA       Date:  2008-04-21       Impact factor: 4.942

2.  In vitro synthesis of modified mRNA for induction of protein expression in human cells.

Authors:  Meltem Avci-Adali; Andreas Behring; Heidrun Steinle; Timea Keller; Stefanie Krajeweski; Christian Schlensak; Hans P Wendel
Journal:  J Vis Exp       Date:  2014-11-13       Impact factor: 1.355

Review 3.  Lipid Nanoparticle Systems for Enabling Gene Therapies.

Authors:  Pieter R Cullis; Michael J Hope
Journal:  Mol Ther       Date:  2017-04-13       Impact factor: 11.454

4.  V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.

Authors:  Elisa Corritore; Yong-Syu Lee; Valentina Pasquale; Daniela Liberati; Mei-Ju Hsu; Catherine Anne Lombard; Patrick Van Der Smissen; Amedeo Vetere; Susan Bonner-Weir; Lorenzo Piemonti; Etienne Sokal; Philippe A Lysy
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

Review 5.  A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs.

Authors:  Karl-Josef Kallen; Andreas Theß
Journal:  Ther Adv Vaccines       Date:  2014-01

6.  Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells.

Authors:  Jutaek Nam; Sejin Son; James J Moon
Journal:  Cell Mol Bioeng       Date:  2017-08-30       Impact factor: 2.321

7.  Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.

Authors:  Marla Karine Amarante; Karen Brajão de Oliveira; Roberta Losi Guembarovski; Ana Cristina da Silva do Amaral Herrera; Alda Losi Guembarovski; Walter Jorge Sobrinho; Julio Cesar Voltarelli; Maria Angelica Ehara Watanabe
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

8.  Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs.

Authors:  Sang-Mi Kim; Mi-Sun Lim; Eun-Hye Lee; Sung Jun Jung; Hee Yong Chung; Chun-Hyung Kim; Chang-Hwan Park
Journal:  Mol Ther       Date:  2017-07-11       Impact factor: 11.454

9.  Reprogramming human fibroblasts to pluripotency using modified mRNA.

Authors:  Pankaj K Mandal; Derrick J Rossi
Journal:  Nat Protoc       Date:  2013-02-21       Impact factor: 13.491

Review 10.  A brilliant disguise for self RNA: 5'-end and internal modifications of primary transcripts suppress elements of innate immunity.

Authors:  Subba Rao Nallagatla; Rebecca Toroney; Philip C Bevilacqua
Journal:  RNA Biol       Date:  2008-07-20       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.